Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNOLIA: ICG NIR Imaging in Head and Neck Cancer
NCT04842162Phase 2Recruiting
- Sponsor
- Gustave Roussy
- Start
- Dec 2020
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of indocyanine green in head and neck cancer (HNC), sponsored by Gustave Roussy. Started Dec 2020; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT04842162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04842162.